AI Summary
Cardinal Health announced two tuck-in acquisitions—AdaptHealth's Diabetes Health and Strive Medical—for about $360 million in cash, expanding its at-Home Solutions platform into diabetes and urology. The deals are expected to be accretive to non-GAAP EPS within 12 months and build on ADS integration progress, including onboarding roughly 500,000 new customers and the ContinuCare Pathway program, signaling stronger home-care scale.
Sentiment Rationale
Accretive earnings in 12 months, expanded addressable market in diabetes/urology, and a demonstrated integration track record with ADS support likely to lift fundamentals and investor sentiment.
Trading Thesis
CAH could see near-term EPS uplift and multiple expansion from these tuck-ins within 12 months.
Market-Moving
- Deal size and accretion guidance could drive CAH stock upside.
- Diabetes and urology expansions broaden addressable home-care market.
- Regulatory approvals risk remains as a near-term hurdle.
- ADS integration track record adds execution credibility.
Key Facts
- Cardinal Health to acquire AdaptHealth Diabetes Health and Strive Medical for $360M.
- Deals expand Cardinal's at-Home Solutions into diabetes and urology. EPS accretion expected in 12 months.
- ADS integration shows scale; 500k new customers onboarded. ContinuCare Pathway launched.
- Deal subject to regulatory approvals. Accretion expected in the first year.
- J.P. Morgan advised on both acquisitions; Skadden and BakerHostetler provided counsel.
Companies Mentioned
- Cardinal Health (CAH): Announces two tuck-ins to expand at-Home Solutions; potential near-term earnings uplift.
- AdaptHealth Corp. (AHCO): Diabetes Health business to be acquired; expands direct-to-patient medical supplies.
- Strive Medical LLC (NA): Private DME provider; adds urology and wound-care capabilities to Cardinal's network.
M&A
Category: M&A. Fits due-to two tuck-in acquisitions expanding Cardinal Health's at-Home Solutions with measurable EPS impact and integration milestones.